Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 5: Focusing on the revised GCP and other new pharmaceutical regulations
Release time：2026-07-06
share:
Previous article：Issue 6: Focusing on regulatory updates in generics, new drug development, and more
next article：Issue 4: Summary of Regulatory Updates from NMPA/CDE and Other Agencies
Back to list
You may also want to read
Issue 13: Monthly Report on Core Policies of Pharmaceutical Regulations for June-July 2026
2026.07.24
Hefei Leecan Pharmaceutical Implements Grid-Connected Photovoltaic System, Painting a 'United Answer' for Green Development
2026.03.27
Issue 2: Monthly Report on Pharmaceutical Regulatory Laws
2026.07.06
